TP53 mutant tumors were associated with increased activity of TFs that have roles in tumor growth, such as ETS2 and FOSB, growth modulation, such as THAP1, CREB3L1 and CEBPZ, and development, such as MEF2C/D, MEOX1 and MSX1. The gene discussed is CEBPZ; the disease is neoplasm.